CROMSOURCE Offers Clients One Trial One Price(TM) Guarantee

WALTHAM, Massachusetts, April 10, 2018 /PRNewswire/ --

CROMSOURCE, an international contract research organization (CRO) providing a comprehensive portfolio of clinical research services to the pharmaceutical, biotechnology, and medical device industries, announced a service offering and guarantee for their clients - One Trial One Price[TM]. This service offering was created based on feedback from existing and prospective clients frustrated with the trend of post-award change orders resulting from an underestimation of the trial requirements by the CRO.

(Logo: )

Built upon CROMSOURCE's deep expertise in successfully and consistently executing clinical programs, clients can be assured that with One Trial One Price[TM] the cost mutually agreed at the contract phase is the price that is paid with no change orders.  This is on the basis that the client allows CROMSOURCE to utilize its extensive experience and knowledge of the clinical trial environment and investigators to ensure that key project milestones are met without delay.

"Drug developers continue to experience an increased number of change orders, causing the cost of clinical trials to continue to rise. To mitigate the impact of this phenomenon, CROMSOURCE launched the One Trial One Price guarantee more than five years ago. With over 20 years of clinical research experience, we are confident in our ability to consistently deliver high quality data on-time and on-budget which allows us to keep our commitment to the original project costs," stated Dr. Oriana Zerbini, Founder and CEO of CROMSOURCE.

Dr. Troy W. McCall, CROMSOURCE Chief Operating Officer, added, "With careful planning and collaboration with all relevant stakeholders, coupled with our clinical research expertise, we are able to guarantee that clients will not pay more than what is agreed during the contracting process. We believe that this is an unprecedented offering in our industry, yet one that we are able to stand behind due to our knowledge, experience, and commitment to complete customer satisfaction."


CROMSOURCE is an ISO-certified, international contract research organization providing a comprehensive portfolio of services to the pharmaceutical, biotechnology, and medical device industries.  Specializing in clinical development and flexible resourcing solutions, we offer a flexible approach to ensure our clients' unique needs are supported. CROMSOURCE is unparalleled in offering an end-to-end guarantee covering trial timelines, enrollment, and price.  CROMSOURCE operates offices across all regions of Europe and North America. For more information, visit


CONTACT: April McCall,, +1-919-896-0280

PR Newswire

Dit persbericht is via ANP Pers Support naar internationale (vak en online) media gestuurd. Heb je nieuws voor buitenlandse journalisten? Bekijk dan onze mogelijkheden of neem contact met ons op.

Verstuur nu éénmalig een persbericht

Verstuur persberichten en beeldmateriaal naar redacties in binnen- en buitenland. Via het ANP-net, het internationale medianetwerk van PR Newswire of met een perslijst op maat.

Direct persbericht versturen
070 - 41 41 234